toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR
Study Group. N Engl J Med 2000;343:1520–1528.
- Curfman GD, Morrissey S, Drazen JM. Expression of concern. N Engl J Med
2005;353:2813–2814.
- Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with
rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med
2005;352:1092–1102.
- Godlee F, Smith J, Marcovitch H. Wakefield’s article linking MMR vaccine and
autism was fraudulent. BMJ 2011;342:c7452.
- Kennedy D. Responding to fraud. Science 2006;314:1353.
- Office of Research Integrity. Case summaries. Available at:
http://ori.hhs.gov/case_summary, accessed 9/29/12.
- Mello MM, Brennan TA. Due process in investigations of research misconduct. N
Engl J Med 2003;349:1280–1286.
- International Committee of Medical Journal Editors. Uniform requirements for
manuscripts submitted to biomedical journals. Available at:
http://www.icmje.org/faq_urm.html, accessed 9/29/12.
- Wislar JS, Flanagin A, Fontanarosa PB, Deangelis CD. Honorary and ghost
authorship in high impact biomedical journals: a cross sectional survey. BMJ
2011;343:d6128.
- Browner WS. Authorship. In: Publishing and presenting clinical research, 2nd ed.
Philadelphia: Lippincott Williams & Willkins, 2006, 137–144.
- Lo B, Field M. Conflict of interest in medical research, education, and practice.
2009. Available at: http://www.iom.edu/Reports/2009/Conflict-of-Interest-in-Medical-
Research-Education-and-Practice.aspx, accessed 11/16/11.
- DeAngelis CD, Fontanarosa PB. Ensuring integrity in industry-sponsored research:
primum non nocere, revisited. JAMA 2010;303:1196–1198.
- DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the
adverse effects of industry influence. Jama 2008;299:1833–1835.
- Joffe S, Miller FG. Equipoise: asking the right questions for clinical trial design.
Nat Rev Clin Oncol 2012;9:230–235.
- Ellenberg SS, Fleming TR, DeMets DL. Data monitoring committees in clinical
trials. Chichester, England: Wiley, 2003.
- Grady C. Payment of clinical research subjects. J Clin Invest 2005;115:1681–1687.
